Insulin Pen and Pump Market

An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus. Insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.

Insulin Pen and Pump Market contains market size and forecasts of Insulin Pen and Pump in global, including the following market information:

• Global Insulin Pen and Pump Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Insulin Pen and Pump Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Insulin Pen and Pump companies in 2021 (%)

The global Insulin Pen and Pump market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
• Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
• The global key manufacturers of Insulin Pen and Pump include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
• surveyed the Insulin Pen and Pump manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulin Pen and Pump Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pen and Pump Market Segment Percentages, by Type, 2021 (%)

• Insulin Pens
• Insulin Pump

Global Insulin Pen and Pump Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pen and Pump Market Segment Percentages, by Application, 2021 (%)

• Hospital & Clinic
• Retail Pharmacy
• Online Sales

Global Insulin Pen and Pump Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Pen and Pump Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Insulin Pen and Pump revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Insulin Pen and Pump revenues share in global market, 2021 (%)
• Key companies Insulin Pen and Pump sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Insulin Pen and Pump sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Eli Lilly
• Sanofi
• BD
• Ypsomed Holding
• Dongbao
• Owen Mumford
• Ganlee
• Medtronic
• Roche
• Insulet Corp
• Tandem Diabetes care
• Valeritas
• SOOIL
• Microport